NCT01150136

Brief Summary

Cystic fibrosis (CF) is the most common lethal, inherited disorder among Caucasians. Choline is an essential vitamin and as a methyl donor is critically needed to support the normal metabolism. Our previous studies have demonstrated that children with CF have depleted levels of choline. The purpose of this study is to gather data on the status of choline and related metabolites in children with Cystic Fibrosis by age and gender. The hypothesis for this study is that in children with CF, deficiency of choline and related metabolites will increase with increasing age.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
57

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2007

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2009

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

April 26, 2010

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 24, 2010

Completed
Last Updated

April 22, 2015

Status Verified

April 1, 2015

Enrollment Period

1.4 years

First QC Date

April 26, 2010

Last Update Submit

April 21, 2015

Conditions

Keywords

cholinecystic fibrosismethyl metabolismoxidative stress

Outcome Measures

Primary Outcomes (1)

  • The change in plasma choline and its metabolites with increasing age in children with CF compared to a healthy reference group without CF

    12 months

Secondary Outcomes (1)

  • The relationship between choline and acetylcholine, and markers of oxidative stress, inflammation and disturbed methyl metabolism

    12 months

Study Arms (1)

1

Children with proven CF and known genotype, age 0-17 yr

Eligibility Criteria

AgeUp to 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Children with proven CF and known genotype, age 0-17 yr who are outpatients of the CF Clinic at the British Columbia (B.C.) Children's Hospital

You may qualify if:

  • children with proven CF and known genotype.
  • age 0-17 yr.
  • outpatients of the CF Clinic at the British Columbia (B.C.) Children's Hospital.
  • Children without CF or any other known disease.

You may not qualify if:

  • children with CF receiving parenteral nutrition during the previous week.
  • children who are hospitalized.
  • children with any health problems other than CF that might in the opinion of the investigators influence dietary choices, growth, choline or methyl metabolites.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Child & Family Research Institute, CF Clinic, BC Children's Hospital

Vancouver, British Columbia, Canada

Location

Related Publications (1)

  • Innis SM, Davidson AG, Bay BN, Slack PJ, Hasman D. Plasma choline depletion is associated with decreased peripheral blood leukocyte acetylcholine in children with cystic fibrosis. Am J Clin Nutr. 2011 Mar;93(3):564-8. doi: 10.3945/ajcn.110.005413. Epub 2011 Jan 12.

MeSH Terms

Conditions

Cystic Fibrosis

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, Diseases

Study Officials

  • Sheila M. Innis, Dr.

    University of British Columbia

    PRINCIPAL INVESTIGATOR
  • A. George F. Davidson, MD

    University of British Columbia

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2010

First Posted

June 24, 2010

Study Start

October 1, 2007

Primary Completion

March 1, 2009

Study Completion

March 1, 2009

Last Updated

April 22, 2015

Record last verified: 2015-04

Locations